ALPS ETF TR - MED BREAKTHGH (SBIO)

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / MED BREAKTHGH
Total 13F shares
1,438,262
Share change
+117,301
Total reported value
$51,309,167
Put/Call ratio
15%
Price per share
$35.75
Number of holders
37
Value change
+$4,226,181
Number of buys
14
Number of sells
12

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q1 2024

As of 31 Mar 2024, ALPS ETF TR - MED BREAKTHGH (SBIO) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,438,262 shares. The largest 10 holders included DAVENPORT & Co LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, WELLS FARGO & COMPANY/MN, NTV Asset Management LLC, Phoenix Wealth Advisors, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Strategic Financial Services, Inc,, and LPL Financial LLC. This page lists 37 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.